Mentions30
Posts5
Latest post1 Jan 2026
Millrose Properties, Inc.2025 portfolio review-1 Jan 2026
Lennar Corporation2025 portfolio review-1 Jan 2026
Mayne Pharma Group Limited2025 portfolio review-1 Jan 2026
Keros Therapeutics, Inc.2025 portfolio review-1 Jan 2026
HilleVax, Inc.2025 portfolio review-1 Jan 2026
CARGO Therapeutics, Inc.2025 portfolio review-1 Jan 2026
Analogue Holdings Limited2025 portfolio review-1 Jan 2026
MACOMPTA.FR2025 portfolio review-1 Jan 2026
Ikena Oncology, Inc.2025 portfolio review-1 Jan 2026
Mitachi Co., Ltd.2025 portfolio review-1 Jan 2026
CEL Corporation2025 portfolio review-1 Jan 2026
Dunedin Enterprise Investment Trust PLC2025 portfolio review-1 Jan 2026
Mitachi Co., Ltd.March portfolio update-1 Apr 2025
CEL CorporationMarch portfolio update-1 Apr 2025
Ikena Oncology, Inc.March portfolio update-1 Apr 2025
CARGO Therapeutics, Inc.March portfolio update-1 Apr 2025
Dunedin Enterprise Investment Trust PLC2024 Portfolio Review-1 Jan 2025
Mitachi Co., Ltd.2024 Portfolio Review-1 Jan 2025
PAR Technology Corporation2024 Portfolio Review-1 Jan 2025
ARCA biopharma, Inc. (now Oruka Therapeutics, Inc.)2024 Portfolio Review-1 Jan 2025
Chen Hsong Holdings Limited2024 Portfolio Review-1 Jan 2025
Analogue Holdings Limited2024 Portfolio Review-1 Jan 2025
OnKure Therapeutics, Inc.2024 Portfolio Review-1 Jan 2025
G & M Holdings Limited2024 Portfolio Review-1 Jan 2025
Atea Pharmaceuticals, Inc.2024 Portfolio Review-1 Jan 2025
CEL Corporation2024 Portfolio Review-1 Jan 2025
Aptinyx Inc.2024 Portfolio Review-1 Jan 2025
Mitachi Co., Ltd.Japanese net-net trading at 7x PE with positive earnings outlook-24 Aug 2024
CEL Corporation2023 Year End Portfolio Review-31 Dec 2023
Aptinyx Inc.2023 Year End Portfolio Review-31 Dec 2023